Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

218
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
218
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

145
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145
Relative Risk01:12

Relative Risk

208
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
208
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

418
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
418
Odds Ratio01:09

Odds Ratio

161
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
161
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

400
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
400

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA hypomethylation enables the transcriptional repressor SlSPL-CNR to control fruit flavor ester biosynthesis.

Nature communications·2026
Same author

An organoid-guided platform for ovarian cancer: enabling prediction of patients' chemotherapy response.

Journal of ovarian research·2026
Same author

Integrated WGCNA and TO-GCN analysis reveals pathways and genes underlying salt tolerance in Sesbania cannabina.

BMC plant biology·2026
Same author

Integrative profiling of glymphatic dysfunction in adolescent subthreshold depression.

Journal of affective disorders·2026
Same author

Recent advances in nanomaterial-based strategies for chronic pain alleviation.

Materials today. Bio·2026
Same author

Rapid and specific detection of hydrazine in environmental samples with a malononitrile functionalized DTTO probe and smartphone based analysis.

Talanta·2026
Same journal

Age at menarche and adverse pregnancy and perinatal outcomes: triangulating evidence from multivariable and Mendelian randomization analyses.

International journal of epidemiology·2026
Same journal

Life-course trajectories of cardiovascular disease risk factors in rural India: Andhra Pradesh Children and Parents Study (APCAPS) 2003-2023.

International journal of epidemiology·2026
Same journal

Estimating and discovering heterogeneous treatment effects using machine learning in epidemiological studies: a practical guide.

International journal of epidemiology·2026
Same journal

Covariates as Random Effects (CaRE): An approach to modeling high-dimensional confounding and effect heterogeneity.

International journal of epidemiology·2026
Same journal

Residential proximity to oil and gas development and risk of gestational diabetes mellitus.

International journal of epidemiology·2026
Same journal

Exploring genetic confounding of the associations between screen time and depressive symptoms in adolescence and early adulthood.

International journal of epidemiology·2026
See all related articles

Related Experiment Video

Updated: Jul 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Communicating and understanding statistical measures when quantifying the between-group difference in competing

Hongji Wu1, Chengfeng Zhang1, Yawen Hou2

  • 1Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, P.R. China.

International Journal of Epidemiology
|September 22, 2023
PubMed
Summary
This summary is machine-generated.

Restricted mean time lost (RMTL) offers a clinically interpretable alternative to hazard-based methods for analyzing competing risks in clinical studies. This approach is robust to proportional hazards assumptions, unlike cause-specific hazard (CSH) and subdistribution hazard (SDH) methods.

Keywords:
Competing riskscause-specific hazardclinical interpretationrestricted mean time lostsubdistribution hazard

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

297

Related Experiment Videos

Last Updated: Jul 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

297

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Epidemiology

Background:

  • Competing risks are prevalent in clinical and epidemiological studies, necessitating robust statistical methods for analysis.
  • Cause-specific hazard (CSH) and subdistribution hazard (SDH) are common but can be limited by proportional hazards assumptions and interpretation challenges.

Purpose of the Study:

  • To compare hazard-based methods (CSH, SDH) with restricted mean time lost (RMTL) for analyzing competing risks.
  • To provide guidance on selecting appropriate methods for between-group difference analysis under competing risks.
  • To highlight the practical interpretation and assumption robustness of RMTL.

Main Methods:

  • Comparative analysis of statistical methods for competing risks.
  • Evaluation of cause-specific hazard (CSH), subdistribution hazard (SDH), and restricted mean time lost (RMTL).
  • Discussion of proportional hazards assumptions and practical interpretation.

Main Results:

  • Hazard-based methods (CSH, SDH) are sensitive to proportional hazards assumptions and may lack intuitive clinical interpretation.
  • Restricted mean time lost (RMTL) provides a clinically interpretable and robust alternative, less dependent on the proportional hazards assumption.
  • The study outlines differences in interpretation, assumption requirements, and time point selection between methods.

Conclusions:

  • Restricted mean time lost (RMTL) is recommended as a clinically meaningful and robust measure for competing risks analysis.
  • The 'cRMTL' R package and guidance are provided to facilitate the application of RMTL.
  • Careful consideration of method assumptions and interpretation is crucial for analyzing competing risks in clinical research.